Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant herpes simplex gB-gD vaccine

Recombinant herpes simplex gB-gD vaccine

US Patent 5750114 · Granted May 12, 1998

Estimated economic value: $6,808,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sodium channel blocker for treatment of loss of superficial sensitivity2015
Sequences from Piscirickettsia salmonis2010
Bioadhesive delivery system for transmucosal delivery of beneficial agents2009
Factor VIII:C nucleic acid molecules2006
Factor VIII:C nucleic acid molecules2006
Factor VIII:C nucleic acid molecules2006
Multiple epitope fusion protein2006
Helicobacter pylori diagnostics2005
Sequences from Piscirickettsia salmonis2005
Compositions comprising polynucleotides encoding human fibroblast growth factor 2005
Hybrid DNA synthesis of mature insulin-like growth factors2003
Herpes simplex virus VP22 vaccines and methods of use2003